AKT1 and prostate carcinoma: Indeed, OXER1 mediates cell proliferation, survival-promoting effects, and inhibition of cell apoptosis in prostate cancer cells, as well as adhesion, migration and invasion through its major signaling pathways involving p38α, PI3K/Akt and FAK [31].